Clinical Trial Update: A Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Recurrent Endometrial Cancer (BEHOLD-Endometrial01) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial to compare GSK5733584 with chemotherapy in recurrent endometrial cancer. Recruitment has not yet begun.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• GSK5733584

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Endometrial | Phase 3 | Status: NOT_YET_RECRUITING